Your session is about to expire
← Back to Search
SPARK for Pediatric Cancer
N/A
Waitlist Available
Led By Lillian Sung, MD
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measure will be completed by all participants on day 5±1 day
Awards & highlights
Study Summary
This trial is testing whether using SPARK, a web-based tool that collects data on symptoms and provides feedback to healthcare providers, improve care for kids compared to the standard of care.
Eligible Conditions
- Pediatric Cancer
- Quality of Life
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measure will be completed by all participants on day 5±1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measure will be completed by all participants on day 5±1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
SSPedi (Symptom Screening in Pediatrics) Total Scores
Secondary outcome measures
Faces Pain Scale-Revised
PedsQL (pediatric Quality of Life) 3.0 Acute Cancer Module
Self-reported individual SSPedi (Symptom Screening in Pediatrics) symptom
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SPARK InterventionExperimental Treatment1 Intervention
Participants will complete symptom screening using SPARK once daily on a study-supplied iPad. For inpatients, daily reminders to complete SSPedi will appear on the iPad. Reports will be available to the child at any time. For outpatients, clinical research associates will provide the iPad in person daily and reports may be viewed at those encounters. The intervention is daily symptom screening with provision of reports to the healthcare team. Severe symptoms will result in email alerts. More specifically, SSPedi reports will be printed daily and provided in the patient chart. On days 1 and 3, an alert will be emailed to the physician providing direct medical care if any symptom is "a lot" or "extremely" bothersome (score 3 or 4 on 0-4 scale). Reports and alerts will have links to SPARK-housed CPGs.
Group II: Standard of Care ArmActive Control1 Intervention
Participants randomized to the control arm will not complete daily symptom screening. They will complete SSPedi on days 1 and 5 to obtain the primary outcome. Health care providers will not be notified of their SSPedi scores and no symptom reports or symptom alerts will be generated.
Find a Location
Who is running the clinical trial?
The Hospital for Sick ChildrenLead Sponsor
687 Previous Clinical Trials
6,944,688 Total Patients Enrolled
Lillian Sung, MDPrincipal InvestigatorThe Hospital for Sick Children
3 Previous Clinical Trials
164 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have difficulty with thinking or understanding.Your medical condition is too severe to participate in the study.You have been diagnosed with cancer or are about to receive a hematopoietic stem cell transplant (HSCT).You have difficulty seeing.
Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care Arm
- Group 2: SPARK Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants aged 25 or above eligible to join this investigation?
"This clinical trial requires subjects to be aged between 8 and 18 years old."
Answered by AI
Are there any new openings for participation in this clinical experiment?
"According to the data posted on clinicaltrials.gov, this study is currently searching for participants. The trial was initially released in September 1st 2018 and had its most recent update on August 23rd 2022."
Answered by AI
Who is eligible to enrol in this trial?
"The clinical trial requires 345 minors aged 8-18 who have an established quality of life to join their program. Furthermore, these participants must be available for a 5 day stay in the hospital or clinic."
Answered by AI
How many persons are participating in the current research endeavor?
"Affirmative. As revealed on clinicaltrials.gov, this trial is recruiting participants and was initially published on September 1st 2018 before being updated most recently on August 23rd 2022. In total, 345 patients are needed to be recruited between a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger